參考文獻 |
1. Nimjee, S.M., C.P. Rusconi, and B.A. Sullenger, Aptamers: an emerging class of therapeutics. Annu. Rev. Med., 2005. 56: p. 555-583.
2. Sun, H. and Y. Zu, A highlight of recent advances in aptamer technology and its application. Molecules, 2015. 20(7): p. 11959-11980.
3. Tuerk, C. and L. Gold, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. science, 1990. 249(4968): p. 505-510.
4. Ellington, A.D. and J.W. Szostak, In vitro selection of RNA molecules that bind specific ligands. nature, 1990. 346(6287): p. 818-822.
5. Stoltenburg, R., C. Reinemann, and B. Strehlitz, SELEX—A (r) evolutionary method to generate high-affinity nucleic acid ligands. Biomolecular engineering, 2007. 24(4): p. 381-403.
6. McKeague, M., et al., Analysis of in vitro aptamer selection parameters. Journal of Molecular Evolution, 2015. 81: p. 150-161.
7. Jenison, R.D., et al., High-resolution molecular discrimination by RNA. Science, 1994. 263(5152): p. 1425-1429.
8. Darmostuk, M., et al., Current approaches in SELEX: An update to aptamer selection technology. Biotechnology advances, 2015. 33(6): p. 1141-1161.
9. Wu, Y.X. and Y.J. Kwon, Aptamers: The “evolution” of SELEX. Methods, 2016. 106: p. 21-28.
10. Ștefan, G., et al., Aptamers in biomedicine: Selection strategies and recent advances. Electrochimica Acta, 2021. 376: p. 137994.
11. Mascini, M., Aptamers and their applications. Analytical and bioanalytical chemistry, 2008. 390(4): p. 987-988.
12. Ferreira, C.S. and S. Missailidis, Aptamer-based therapeutics and their potential in radiopharmaceutical design. Brazilian archives of biology and technology, 2007. 50: p. 63-76.
13. Jayasena, S.D., Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clinical chemistry, 1999. 45(9): p. 1628-1650.
14. Iliuk, A.B., L. Hu, and W.A. Tao, Aptamer in bioanalytical applications. Analytical chemistry, 2011. 83(12): p. 4440-4452.
15. Nakatsuka, N., et al., Aptamer–field-effect transistors overcome Debye length limitations for small-molecule sensing. Science, 2018. 362(6412): p. 319-324.
16. Sheibani, S., et al., Extended gate field-effect-transistor for sensing cortisol stress hormone. Communications materials, 2021. 2(1): p. 10.
17. Hu, W.-P., et al., Ultrasensitive Detection of Interleukin 6 by Using Silicon Nanowire Field-Effect Transistors. Sensors, 2023. 23(2): p. 625.
18. Vu, C.-A., et al., Signal enhancement of silicon nanowire field-effect transistor immunosensors by RNA aptamer. ACS omega, 2019. 4(12): p. 14765-14771.
19. 潘品憲, 利用抗原結合區段之抗體片段探針於矽奈米線場效電晶體來改善抗原檢測濃度極限之研究, in 化學工程與材料工程學系. 2020, 國立中央大學: 桃園縣. p. 112.
20. Cardiovascular diseases (CVDs). 2021; Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
21. Noncommunicable diseases. 2022; Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
22. Du, X., et al., Progress, opportunities, and challenges of troponin analysis in the early diagnosis of cardiovascular diseases. Analytical Chemistry, 2021. 94(1): p. 442-463.
23. Thygesen, K., et al., Fourth universal definition of myocardial infarction (2018). Circulation, 2018. 138(20): p. e618-e651.
24. Aydin, S., et al., Biomarkers in acute myocardial infarction: current perspectives. Vascular health and risk management, 2019: p. 1-10.
25. Szunerits, S., et al., Electrochemical cardiovascular platforms: Current state of the art and beyond. Biosensors and Bioelectronics, 2019. 131: p. 287-298.
26. Hasanzadeh, M., et al., Electrochemical nano-immunosensing of effective cardiac biomarkers for acute myocardial infarction. TrAC Trends in Analytical Chemistry, 2013. 49: p. 20-30.
27. Ahammad, A.S., et al., Electrochemical detection of cardiac biomarker troponin I at gold nanoparticle-modified ITO electrode by using open circuit potential. Int. J. Electrochem. Sci, 2011. 6(6): p. 1906-1916.
28. Gaze, D.C. and P.O. Collinson, Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Annals of clinical biochemistry, 2008. 45(4): p. 349-355.
29. Wu, A.H., et al., National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clinical chemistry, 1999. 45(7): p. 1104-1121.
30. Anderson, J.L., et al., ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Journal of the American College of Cardiology, 2007. 50(7): p. e1-e157.
31. Katrukha, A.G., et al., Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clinical chemistry, 1997. 43(8): p. 1379-1385.
32. Rubini Gimenez, M., et al., Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. European heart journal, 2014. 35(34): p. 2303-2311.
33. Jacobs, L., A. Mingels, and M. van Dieijen-Visser, Cardiac biomarkers in end-stage renal disease. Sahay M. Chronic Kidney Disease and Renal Transplantation. Rijeka, Croatia: InTech, 2012: p. 147-60.
34. Apple, F.S., et al., Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clinical chemistry, 2017. 63(1): p. 73-81.
35. UK, C.B., et al., 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. 2015.
36. Koechlin, L., et al., Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm. American Heart Journal, 2023. 255: p. 58-70.
37. Larsson, A., R. Greig-Pylypczuk, and A. Huisman, The state of point-of-care testing: a European perspective. Upsala journal of medical sciences, 2015. 120(1): p. 1-10.
38. Stopyra, J.P., et al., Point-of-care troponin testing during ambulance transport to detect acute myocardial infarction. Prehospital Emergency Care, 2020. 24(6): p. 751-759.
39. Jo, H., et al., Electrochemical aptasensor of cardiac troponin I for the early diagnosis of acute myocardial infarction. Analytical chemistry, 2015. 87(19): p. 9869-9875.
40. Zhang, J., T. Lakshmipriya, and S.C. Gopinath, Electroanalysis on an Interdigitated Electrode for High-Affinity Cardiac Troponin I Biomarker Detection by Aptamer–Gold Conjugates. ACS omega, 2020. 5(40): p. 25899-25905.
41. Rodrigues, T., et al., Highly performing graphene-based field effect transistor for the differentiation between mild-moderate-severe myocardial injury. Nano Today, 2022. 43: p. 101391.
42. Qiao, X., et al., Novel electrochemical sensing platform for ultrasensitive detection of cardiac troponin I based on aptamer-MoS2 nanoconjugates. Biosensors and Bioelectronics, 2018. 113: p. 142-147.
43. Lopa, N.S., et al., Simple, low-cost, sensitive and label-free aptasensor for the detection of cardiac troponin I based on a gold nanoparticles modified titanium foil. Biosensors and Bioelectronics, 2019. 126: p. 381-388.
44. Shen, J., et al., Recent development of sandwich assay based on the nanobiotechnologies for proteins, nucleic acids, small molecules, and ions. Chemical Reviews, 2014. 114(15): p. 7631-7677.
45. Jo, H., et al., Highly sensitive amperometric detection of cardiac troponin I using sandwich aptamers and screen-printed carbon electrodes. Talanta, 2017. 165: p. 442-448.
46. Kitte, S.A., et al., Plasmon-enhanced quantum dots electrochemiluminescence aptasensor for selective and sensitive detection of cardiac troponin I. Talanta, 2021. 221: p. 121674.
47. Luo, Z., et al., DNA nanotetrahedron linked dual-aptamer based voltammetric aptasensor for cardiac troponin I using a magnetic metal-organic framework as a label. Microchimica Acta, 2019. 186: p. 1-10.
48. Tu, D., A. Holderby, and G.L. Coté, Aptamer-based surface-enhanced resonance Raman scattering assay on a paper fluidic platform for detection of cardiac troponin I. Journal of biomedical optics, 2020. 25(9): p. 097001-097001.
49. Twerenbold, R., et al., Outcome of applying the ESC 0/1-hour algorithm in patients with suspected myocardial infarction. Journal of the American College of Cardiology, 2019. 74(4): p. 483-494.
50. Nowak, R.M., et al., Performance of novel high-sensitivity cardiac troponin I assays for 0/1-hour and 0/2-to 3-hour evaluations for acute myocardial infarction: results from the HIGH-US study. Annals of emergency medicine, 2020. 76(1): p. 1-13.
51. Baryeh, K., et al., Introduction to medical biosensors for point of care applications, in Medical biosensors for point of care (POC) applications. 2017, Elsevier. p. 3-25.
52. Savonnet, M., et al., Recent advances in cardiac biomarkers detection: From commercial devices to emerging technologies. Journal of Pharmaceutical and Biomedical Analysis, 2021. 194: p. 113777.
53. Kong, T., et al., CMOS-compatible, label-free silicon-nanowire biosensors to detect cardiac troponin I for acute myocardial infarction diagnosis. Biosensors and Bioelectronics, 2012. 34(1): p. 267-272.
54. Chua, J.H., et al., Label-free electrical detection of cardiac biomarker with complementary metal-oxide semiconductor-compatible silicon nanowire sensor arrays. Analytical chemistry, 2009. 81(15): p. 6266-6271.
55. Kim, K., et al., Silicon nanowire biosensors for detection of cardiac troponin I (cTnI) with high sensitivity. Biosensors and Bioelectronics, 2016. 77: p. 695-701.
56. Prakash, M.D., et al., A study of an ultrasensitive label free silicon nanowire FET biosensor for cardiac troponin I detection. Silicon, 2022. 14(10): p. 5683-5690.
57. Chang, S.-M., et al., Utilization of silicon nanowire field-effect transistors for the detection of a cardiac biomarker, cardiac troponin I and their applications involving animal models. Scientific reports, 2020. 10(1): p. 22027.
58. Lee, C.-S., S.K. Kim, and M. Kim, Ion-sensitive field-effect transistor for biological sensing. Sensors, 2009. 9(9): p. 7111-7131.
59. Yang, F. and G.-J. Zhang, Silicon nanowire-transistor biosensor for study of molecule-molecule interactions. Reviews in Analytical Chemistry, 2014. 33(2): p. 95-110.
60. Syu, Y.-C., W.-E. Hsu, and C.-T. Lin, Field-effect transistor biosensing: Devices and clinical applications. ECS Journal of Solid State Science and Technology, 2018. 7(7): p. Q3196.
61. Cui, Y., et al., Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. science, 2001. 293(5533): p. 1289-1292.
62. Chang, R., et al., Water near bioinert self-assembled monolayers. Polymer Journal, 2018. 50(8): p. 563-571.
63. Ulman, A., Formation and structure of self-assembled monolayers. Chemical reviews, 1996. 96(4): p. 1533-1554.
64. Kind, M. and C. Wöll, Organic surfaces exposed by self-assembled organothiol monolayers: Preparation, characterization, and application. Progress in Surface Science, 2009. 84(7-8): p. 230-278.
65. Sagiv, J., Organized monolayers by adsorption. 1. Formation and structure of oleophobic mixed monolayers on solid surfaces. Journal of the American Chemical Society, 1980. 102(1): p. 92-98.
66. Capecchi, G., et al., Adsorption of CH 3 COOH on TiO 2: IR and theoretical investigations. Research on Chemical Intermediates, 2007. 33: p. 269-284.
67. Wang, G.M., W.C. Sandberg, and S.D. Kenny, Density functional study of a typical thiol tethered on a gold surface: ruptures under normal or parallel stretch. Nanotechnology, 2006. 17(19): p. 4819.
68. Zürcher, S., et al., Biomimetic surface modifications based on the cyanobacterial iron chelator anachelin. Journal of the American Chemical Society, 2006. 128(4): p. 1064-1065.
69. Huang, C.-J., Advanced surface modification technologies for biosensors, in Chemical, gas, and biosensors for internet of things and related applications. 2019, Elsevier. p. 65-86.
70. Mariotti, M.P., et al., Hydrolysis of whey lactose by immobilized β-galactosidase. Brazilian Archives of Biology and Technology, 2008. 51: p. 1233-1240.
71. Merkel, R., et al., Energy landscapes of receptor–ligand bonds explored with dynamic force spectroscopy. Nature, 1999. 397(6714): p. 50-53.
72. Timin, A.S., et al., Immobilization of bovine serum albumin onto porous poly (vinylpyrrolidone)-modified silicas. Industrial & Engineering Chemistry Research, 2014. 53(35): p. 13699-13710.
73. He, M., et al., Zwitterionic materials for antifouling membrane surface construction. Acta biomaterialia, 2016. 40: p. 142-152.
74. Vu, C.-A., et al., Improved biomarker quantification of silicon nanowire field-effect transistor immunosensors with signal enhancement by RNA aptamer: Amyloid beta as a case study. Sensors and Actuators B: Chemical, 2021. 329: p. 129150.
75. Carrara, S., et al., New insights for using self-assembly materials to improve the detection stability in label-free DNA-chip and immuno-sensors. Biosensors and Bioelectronics, 2009. 24(12): p. 3425-3429.
76. Sharma, S., K.C. Popat, and T.A. Desai, Controlling nonspecific protein interactions in silicon biomicrosystems with nanostructured poly (ethylene glycol) films. Langmuir, 2002. 18(23): p. 8728-8731.
77. Armbruster, D.A. and T. Pry, Limit of blank, limit of detection and limit of quantitation. The clinical biochemist reviews, 2008. 29(Suppl 1): p. S49.
78. Komarova, N., et al., Aptamers Targeting Cardiac Biomarkers as an Analytical Tool for the Diagnostics of Cardiovascular Diseases: A Review. Biomedicines, 2022. 10(5): p. 1085.
79. 林弘庾, 探討檢測微核醣核酸時核酸雜交反應誘發之反離子重新分布對矽奈米線場效電晶體電場效應的影響, in 化學工程與材料工程學系. 2022, 國立中央大學: 桃園縣. p. 107.
80. Vu, C.-A., et al., Optimizing surface modification of silicon nanowire field-effect transistors by polyethylene glycol for MicroRNA detection. Colloids and Surfaces B: Biointerfaces, 2022. 209: p. 112142. |